Industry-Sponsored Research: A More Comprehensive Alternative
2006
A Proposal for Better Pharmaceutical Research Regulation
publication
Author Information
Author(s): Peter Mansfield
Primary Institution: Healthy Skepticism Inc.
Hypothesis
How can the regulation of clinical research sponsored by pharmaceutical companies be improved?
Conclusion
The proposed changes could lead to lower drug prices and better quality research by separating funding for different pharmaceutical functions.
Supporting Evidence
- The proposal suggests a Collegiate Research Council funded by drug companies to manage research.
- It argues that separating funding for different functions of pharmaceutical companies can improve quality and reduce costs.
- The recommendations aim to align incentives for better performance in research and education.
Takeaway
This study suggests that if we change how drug companies are funded for research, education, and promotion, we can make medicines cheaper and safer for everyone.
Potential Biases
Potential conflicts of interest due to funding from organizations that could benefit from the recommendations.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website